Cargando…

Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease

BACKGROUND: The treatment effects on hospitalization for heart failure (hHF) from sodium-glucose cotransporter 2 (SGLT2) inhibitors may vary among type 2 diabetes (T2D) patients depending on whether or not they have established atherosclerotic cardiovascular diseases (ASCVD). We aimed to examine dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Shih-Chieh, Chang, Kai-Cheng, Lin, Swu-Jane, Chang, Shang-Hung, Hung, Ming-Jui, Chan, Yuk-Ying, Lai, Edward Chia-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542324/ https://www.ncbi.nlm.nih.gov/pubmed/34688282 http://dx.doi.org/10.1186/s12933-021-01406-3

Ejemplares similares

Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients
por: Shao, Shih-Chieh, et al.
Publicado: (2020)

Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study
por: Shao, Shih-Chieh, et al.
Publicado: (2019)

SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews
por: Shao, Shih-Chieh, et al.
Publicado: (2020)

Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan
por: Su, Yu-Chen, et al.
Publicado: (2022)

Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?
por: Shao, Shih-Chieh, et al.
Publicado: (2019)

Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study
por: Huang, Wei-Ching, et al.
Publicado: (2023)

Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study
por: Shao, Shih-Chieh, et al.
Publicado: (2023)

Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan’s National Health Insurance Claims Database
por: Liao, Shu-Chen, et al.
Publicado: (2022)

Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis
por: Chen, Yih-Ting, et al.
Publicado: (2020)

Workload of pharmacists and the performance of pharmacy services
por: Shao, Shih-Chieh, et al.
Publicado: (2020)

Associations of thiazide use with skin cancers: a systematic review and meta-analysis
por: Shao, Shih-Chieh, et al.
Publicado: (2022)

Risk assessment indicators and brachial-ankle pulse wave velocity to predict atherosclerotic cardiovascular disease
por: Ko, Hung-Ju, et al.
Publicado: (2022)

Cardiovascular and metabolic risk of antipsychotics in children and young adults: a multinational self-controlled case series study
por: Man, Kenneth K. C., et al.
Publicado: (2021)

Taiwan’s National Health Insurance Research Database: past and future
por: Hsieh, Cheng-Yang, et al.
Publicado: (2019)

Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers
por: Gessner, Arne, et al.
Publicado: (2022)

Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patients
por: Hwang, In-Chang, et al.
Publicado: (2020)

Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System
por: Vassy, Jason L., et al.
Publicado: (2020)

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
por: Chang, Kai-Cheng, et al.
Publicado: (2020)

Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2022)

Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study
por: Levin, Michael G., et al.
Publicado: (2021)

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis
por: McGuire, Darren K., et al.
Publicado: (2020)

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease
por: Smidt, Lisanne C. A., et al.
Publicado: (2021)

Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease
por: Wang, Chun-Cheng, et al.
Publicado: (2017)

Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2019)

Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
por: Hatipsoylu, Erdinç, et al.
Publicado: (2019)

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
por: Bode, David, et al.
Publicado: (2021)

Association of Long-term Use of Antihypertensive Medications With Late Outcomes Among Patients With Aortic Dissection
por: Chen, Shao-Wei, et al.
Publicado: (2021)

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
por: Li, Yan-Rong, et al.
Publicado: (2018)

The association between SGLT2 inhibitors and new-onset arrhythmias: a nationwide population-based longitudinal cohort study
por: Chen, Hung-Yi, et al.
Publicado: (2020)

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Detecting Potential Adverse Reactions of Sulpiride in Schizophrenic Patients by Prescription Sequence Symmetry Analysis
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2014)

The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis
por: Chao, Chia-Ter, et al.
Publicado: (2021)

Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases
por: Deo, Salil V., et al.
Publicado: (2023)

Analysis of Anticoagulation Therapy and Anticoagulation-Related Outcomes Among Asian Patients After Mechanical Valve Replacement
por: Huang, Jo-Ting, et al.
Publicado: (2022)

High or low calcium intake increases cardiovascular disease risks in older patients with type 2 diabetes
por: Huang, Jui-Hua, et al.
Publicado: (2014)

Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Fetterman, Jessica L., et al.
Publicado: (2016)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

A meta‐analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases
por: Wang, Li, et al.
Publicado: (2019)

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor
por: Lee, Hsin-Fu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r608put4op7v6quv2h98ldqoot